Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|July 4, 2008
Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonistsYong Gong, J Kent Barbay, Mieke Buntinx, et al.Bioorganic & Medicinal Chemistry Letters|April 2, 2008
Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonistsJ Kent Barbay, Yong Gong, Mieke Buntinx, et al.Bioorganic & Medicinal Chemistry Letters|January 30, 2008
Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonistsYong Gong, J Kent Barbay, Edward S Kimball, et al.Bioorganic & Medicinal Chemistry Letters|March 26, 2013
Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonistsBrian C Shook, Devraj Chakravarty, J Kent Barbay, et al.Bioorganic & Medicinal Chemistry Letters|April 24, 2019
3-Substituted Quinolines as RORγt Inverse AgonistsVirginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.Journal of Medicinal Chemistry|May 26, 2006
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonistsYong Gong, J Kent Barbay, Alexey B Dyatkin, et al.ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.Journal of Medicinal Chemistry|January 14, 2012
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Nathaniel Wallace, et al.Bioorganic & Medicinal Chemistry Letters|March 27, 2010
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonistsBrian C Shook, Stefanie Rassnick, Devraj Chakravarty, et al.Pageof 2